Zelsuvmi: a novel approach to treating molluscum contagiosum
- PMID: 40337381
- PMCID: PMC12055137
- DOI: 10.1097/MS9.0000000000002939
Zelsuvmi: a novel approach to treating molluscum contagiosum
Conflict of interest statement
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. The authors declare that they have no financial conflict of interest with regard to the content of this report.
References
-
- Olatunji G, Kokori E, Kwape JM, et al. . Berdazimer: a novel nitric oxide therapy in treating molluscum contagiosum. J Med Surg Public Health 2024;2:100061.
-
- Keam SJ. Berdazimer topical gel, 10.3%: first approval. Drugs 2024;84:363–68. - PubMed
-
- U.S. Food and drug administration approves ZELSUVMI™ as a first-in-class medication for the treatment of molluscum contagiosum; n.d.. https://investor.ligand.com/news-and-events/press-releases/news-details/....
Publication types
LinkOut - more resources
Full Text Sources